Herpesviruses hijack ISGylation to promote viral capsid assembly
Herpesviruses are common pathogens of the oral cavity, yet how they interact with other oral microbes are poorly understood. Using murine gamma-herpesvirus 68 (MHV68) as a model for human gamma-herpesviruses, we find that ISGylation is hijacked to facilitate viral capsid assembly and lytic replication. Coinfection with the oral Aggregatibacter actinomycetemcomitans ( A.actinomycetemcomitans ) and MHV68 synergistically induced interferon-stimulated gene 15 (ISG15) expression and global ISGylation. Proteomic profiling revealed viral structural proteins as the dominant targets of ISGylation in MHV68-infected cells. Genetic ablation of ISGylation, using ISGylation-resistant recombinant MHV68 and ISG15-deficient mouse embryonic fibroblasts (MEFs), demonstrated that ISGylation of the major capsid protein ORF25 is required for efficient capsid assembly and maturation into the infectious C-type virions. Notably, introduction of a de novo ISGylation site into the ISGylation-resistant MHV68 was sufficient to restore ISGylation, capsid assembly, and virion maturation. Consistent with these findings, A. actinomycetemcomitans failed to enhance MHV68 lytic replication in ISG15-deficient MEFs. Extending this mechanism to representative herpesviruses, we showed that ISGylation of major capsid proteins is broadly required for efficient lytic replication. Together, these findings uncover a previously unrecognized strategy by which herpesviruses exploit an ISG15 innate immune effector, amplified by microbial coinfection, to promote virion assembly and productive infection.
Authors
- Wayne W. Yeh (ORCID: https://orcid.org/0000-0002-4477-1523)
- Jianglin Zhang (ORCID: https://orcid.org/0009-0005-3847-8661)
- Pinghui Feng (ORCID: https://orcid.org/0000-0002-8494-0205)
- Zhenfeng Shu
- Casey Chen (ORCID: https://orcid.org/0000-0002-0331-0181)
- Shutong Li (ORCID: https://orcid.org/0000-0001-7378-5740)
- Wen Fu (ORCID: https://orcid.org/0009-0004-6459-6066)
- Joshua Munger (ORCID: https://orcid.org/0000-0001-5379-9440)
- Rui Wang (ORCID: https://orcid.org/0000-0002-4119-8274)
- Chao Qin (ORCID: https://orcid.org/0000-0003-0393-1751)
- Jae U. Jung (ORCID: https://orcid.org/0000-0003-4559-8774)
- Xinchi Xie (ORCID: https://orcid.org/0000-0001-5703-2589)
- Weiming Yuan (ORCID: https://orcid.org/0000-0002-4780-7157)
- Lin Chen (ORCID: https://orcid.org/0000-0003-4798-6199)
- Shu Feng (ORCID: https://orcid.org/0000-0002-5372-4497)
- Sean Sasaki
- Yue Zheng
- Yongzhen Liu (ORCID: https://orcid.org/0009-0002-1686-7752)
- Natalia Tjokro (ORCID: https://orcid.org/0009-0006-0960-9797)
- Takeru Saito
Institutions
- University of Southern California (US)
- Cleveland Clinic (US)
- University of Rochester (US)
Publication Details
- Journal
- Science Advances
- Published
- 2026-09-11
- DOI
- https://doi.org/10.1126/sciadv.aeg7872
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health